+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Recent advances in cell biology, diagnosis, and therapy of gastrointestinal stromal tumor (GIST)



Recent advances in cell biology, diagnosis, and therapy of gastrointestinal stromal tumor (GIST)



Cancer Biology and Therapy 3(3): 251-258



The understanding of mesenchymal neoplasms of the gastrointestinal tract has evolved dramatically over the last two decades since gastrointestinal stromal tumor (GIST) was described as the most common stromal tumor arising anywhere from the esophagus to the ano-rectum. Although morphologically similar to other benign and malignant smooth muscle and neural stromal neoplasms, GIST constitutes a distinct group of rare gastrointestinal tract tumors that originate from the interstitial cells of Cajal, regulators of gut peristalsis that normally express CD117, which is the product of the c-KIT proto-oncogene that encodes a tyrosine kinase receptor that regulates cellular proliferation in GISTs. Virtually all GISTs occur from mutations of the c-KIT oncogene and exhibit consistent expression of c-KIT (CD117), which is considered the most specific criterion for a diagnosis of GIST. Gastrointestinal stromal tumors vary in their behavior and several features have to be considered to assess their malignant potential. The advent of sophisticated imaging techniques for the evaluation and sampling of stromal tumors of the gastrointestinal tract has resulted in improved detection of GISTs. The identification of a novel tumor-specific target in c-KIT resulted in the development of a tyrosine kinase-inhibitor (imatinib mesylate) that provides an encouraging option for treating GISTs. This article reviews recent advances in the understanding of the cell biology, diagnosis, and therapy of GISTS.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 050125681

Download citation: RISBibTeXText

PMID: 14726714


Related references

Recent Advances in Cell Biology, Diagnosis and Therapy of Gastrointestinal Stroma Tumor (GIST). Cancer Biology & Therapy 3(3): 251-258, 2004

Recent advances and novel agents for gastrointestinal stromal tumor GIST. Journal of Hematology & Oncology 5(1): 21, 2012

Recent advances and novel agents for gastrointestinal stromal tumor (GIST). Journal of Hematology & Oncology 5: 21-21, 2012

Intraoperative diagnosis of a functional paraganglioma presenting as a gastrointestinal stromal cell tumor (GIST). Journal of Clinical Anesthesia 21(1): 57-60, 2009

Gastrointestinal stromal tumor (GIST): advances in 2013. Ceskoslovenska Patologie 50(2): 76-80, 2014

Clinical pathology of gastrointestinal stromal tumor (GIST): With special reference to change of the cencept of gastrointestinal mesenchymal tumor (GIMT) and the definition and organ specificity of GIST. Stomach and Intestine (Tokyo) 36(9): 1113-1127, 2001

Recent progress in gastrointestinal stromal tumor (GIST). Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(9): 1495-1501, 2002

Recent advances and novel agents forgastrointestinal stromal tumor GIST. 2012

Is gastrointestinal stromal tumor (GIST) originating from the rectovaginal septum GIST or extra-GIST (EGIST)? A case report with literature review. European Journal of Gynaecological Oncology 36(6): 750-754, 2016

Myxoid epithelioid gastrointestinal stromal tumor (GIST) with mast cell infiltrations: a subtype of GIST with mutations of platelet-derived growth factor receptor alpha gene. Human Pathology 35(10): 1223-1230, 2004

Histopathologic diagnosis of gastrointestinal stromal tumor (GIST). Orvosi Hetilap 146(18 Suppl 1): 923-928, 2005

Diagnosis and treatment of leiomyoma, neurogenic tumor and gastrointestinal stromal tumor (GIST) in the esophagus. Stomach and Intestine (Tokyo) 39(4): 539-551, 2004

The role of the image on the diagnosis of the gastrointestinal stromal tumor (GIST). Revista de Gastroenterologia de Mexico 76(1): 52-54, 2014

Nanoneoadjuvant therapy of gastrointestinal stromal tumor (GIST). Annals of Surgical Oncology 16(4): 799-800, 2009

DOG1 for the diagnosis of gastrointestinal stromal tumor (GIST): Comparison between 2 different antibodies. Applied Immunohistochemistry and Molecular Morphology 18(4): 333-337, 2010